Biogen Inc (BIIB) Tacks on $7B in Market Value on Buyout Talk

Biogen Inc (NASDAQ:BIIB) just made a huge move out of thin air Tuesday evening, spiking 9.5% to $330 as of this writing. Until the surge, BIIB stock was trading in the red in the sub-$300 range. So why the sudden interest in this biotech? Well, those pesky “people familiar with the matter” are at it again,... More 

How Merck & Co., Inc. Ranks As a Top Analyst Pick (MRK)

A study of analyst recommendations at the major brokerages shows that Merck is the #15 broker pick out of the 30 Dow stocks More 

10 Stellar Dow Jones Stocks to Buy for Q3

The list of Dow Jones stocks primed for more outperformance in the third quarter and beyond is topped by some surprising names. More 

7 Pharmaceuticals Stocks to Buy Now

This week, 7 Pharmaceuticals stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More 

The Top 10 S&P 500 Dividend Stocks to Buy Now

These blue-chip dividend stocks to buy may not sport the highest yields available, but they sure look like total return winners. More 

70 Actions to Take on Monday’s Rally

During these busy times it pays to stay on top of the latest profit opportunities. Today's blog post features my latest Portfolio Grader rankings More 

4 Pharmaceuticals Stocks to Sell Now

The ratings of 4 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More